Skip to main content
. Author manuscript; available in PMC: 2022 Jan 1.
Published in final edited form as: Pediatr Blood Cancer. 2020 Oct 7;68(1):e28719. doi: 10.1002/pbc.28719

TABLE 1.

Presenting clinical characteristics of patients with T-ALL on DFCI 05-001 and 11-001

Patient Characteristic N (%) non ETP T-ALL
N (%)
ETP-ALL*
N (%)
p-value
No. Pts. 123 100 21
Protocol
 05-001 97 (79) 78 (78) 17 (81) 0.99
 11-001 26 (21) 22 (22) 4 (19)
Age
<10 yrs 67 (54) 58 (58) 7 (33) 0.054
 ≥10 yrs 56 (46) 42 (42) 14 (67)
 median (range) yrs. 8.5 (1.2, 17.9) 8.2 (1.2, 18) 11.1 (2.9, 17.9) 0.086
Sex
 Male 91 (74) 77 (77) 13 (62) 0.17
 Female 32 (26) 23 (23) 8 (38)
WBC
<50 K 53 (43) 35 (35) 17 (81) 0.0002
 ≥50 K 70 (57) 65 (65) 4 (19)
 median (range) 62.4 (0.9, 905.0) 81.1 (1.1, 905.0) 13.4 (1.0, 259.2) 0.0001
Mediastinal Mass
 Yes 55 (45) 48 (48) 6 (29) 0.15
 No 68 (55) 52 (52) 15 (71)
CNS Status
 1 71 (58) 59 (59) 11 (52) 0.76
 2 42 (34) 33 (33) 8 (38)
 3 10 (8) 8 (8) 2 (10)
*

Includes 1 case of probable ETP, which was not assessed for CD1a status

Comparison of non ETP-ALL and ETP-ALL

Of the 123 patients with T-ALL enrolled, sufficient data to evaluate ETP status was available for 121 patients